The economic burden of COPD exacerbations

COPD. 2010 Jun;7(3):159-61. doi: 10.3109/15412555.2010.485098.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / economics*
  • Anti-Bacterial Agents / therapeutic use
  • Bronchodilator Agents / economics*
  • Bronchodilator Agents / therapeutic use
  • Cost of Illness*
  • Glucocorticoids / economics*
  • Glucocorticoids / therapeutic use
  • Health Care Costs*
  • Humans
  • Morbidity / trends
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / economics*
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Recurrence
  • Survival Rate / trends

Substances

  • Anti-Bacterial Agents
  • Bronchodilator Agents
  • Glucocorticoids